HEALTHTECH LEADERS AGENDA
Choose your topic ... Biotech Healthtech Medtech
*** 17:40 - 20:00 Wednesday September 13 - Stay with us for the networking reception ***
Day 1 – Wednesday, September 13
09:00 LSX Welcome Address
Jade Osei-Tutu, Sr. Conference Director, LSX
09:10 Keynote Panel: Is Data Pharma's Next Blockbuster? Big Pharma’s Global Digital Health Priorities and Strategy
Having made their way from the basement to the executive suite, technologies like artificial intelligence (AI) and machine learning are now shaping the future of the life sciences industry – and data is the foundation that drives these technologies forward. However, without the right tools to help manage and process it, the best data in the world can quickly become useless.
Embracing data is a crucial step on the journey to building a digitally transformed company and evolving your technology strategy across the entire life sciences lifecycle. Solutions to good data management can help save pharmaceutical companies billions of dollars and significantly improve the time it takes to bring life-saving new drugs to market, but the industry is still fraught with questions when it comes to centralizing, standardizing, and managing data – then transforming that data into action.
Four leaders in life science’s data transformation will discuss those questions, addressing the challenges and opportunities that come with employing data to effectively deliver on a patient-centric mission.
Jane Urban, VP, Head of Data, Digital & Technology for Global Medical and Commercial, Takeda
Amy West, Head of US Digital Transformation & Innovation, Novo Nordisk
Charles Haddad, AVP/Head Product Strategy, Global Digital Health, Eli Lilly
Meghan Dierks, Chief Data Officer, Komodo Health
9:50 Keynote Panel: Achieving Scale and Profitability in Healthtech Businesses
Chris Wasden, Chief Strategy Officer, Twill
John Drakenberg, CEO, Alex Therapeutics
Gabriela Perez, Chief Commercial Officer, Big Health
Randall Stanicky, CFO, Click Therapeutics
10:30 Morning Break
11:00 Panel: Overcoming the Challenges of Developing Digital Health Products-A Pharma Perspective
Amir Zur, Executive Director, Head of R&D Digital Health Products, Takeda Pharmaceuticals
Suhas Krishna, VP, Head of Product Management, Digital Health, BMS
Ofer Waks, Director, Digital Strategy and Innovation, Pfizer
12:00 Panel: How are New Digital Innovations Revolutionising Clinical Trials?
The era of clinical trials as we’ve known them is coming to an end. The rising costs of running a trial, coupled with the commercial risks of failure, are unsustainable. This disruptive state is driving the adoption of new technologies and catalysing the digital transformation of clinical trials.
Josh Rose, VP, Head of Clinical Trial Delivery, Site Solutions & Strategy, CVS Health
12:50 Lunch Break
13:40 Panel: Driving Greater Adoption of Digital Therapeutics into Healthcare Systems
This discussion will focus on what happens once effective DTx is solution built and clinically validated, how do we get it into the hands of those that need it the most? Hear the lessons learned from healthcare leaders on the forefront of the digital therapeutics’ revolution.
Pierre Leurent, President, Digital Health, Aptar Pharma
Andy Molnar, CEO, Digital Therapeutics Alliance
Eddie Martucci, Founder & CEO, Akili Interactive
Jonathan Schremp, Director of Digital Health Engagement, Banner Health
14:40 Creating Successful Digital Health-Pharma Partnerships and Collaborations
15:30 Afternoon Break
16:00 Revolutionizing Healthcare - Exploring New Applications of AI/ML
How are we using data technology and advanced analytics (artificial intelligence, machine learning, and deep learning) to advance our understanding of disease and deliver breakthroughs that change patients' lives?
Neil Sahota, United Nations Artificial Intelligence Advisor & CEO, ACSILabs
Martin Gershon, Managing Partner & CIO, Endeavor Venture Fund
16:40 Fireside Chat: Driving Growth, Innovation, and Investment in Women’s Health
Discussing the dynamics in the Women’s Health space, drivers in the market, the vision for the growth of technology innovations in women’s health, and how do we as a sector plan to empower women globally?
Sapna Rao, Head of Consumer Strategy for Women’s Health, Philips
Elizabeth Bailey, Managing Director, RH Capital
17:00 Panel: Playing the Long Game-Healthtech Investment, Deals and Dollars
Due to the complexities within health technology and the health system’s complex regulation, it can be argued that a truly long-term approach is required from partners and investors. Despite the dip in digital health funding in 2022, the potential for long-term success in the healthtech space remains very real with the right strategies in place. This session will discuss the growth in partnerships with venture capital firms, the changing funding environment, and what healthtech investment activity in 2023 looks like so far.
Robert Garber, Partner, 7wire ventures
Nathan Sundheimer, Head, US Healthcare Partnerships, Plug and Play Tech Centre
Vishal Gulati, Managing Director, Recode Ventures
17:40 Drinks Reception
Day 2 – Thursday, September 14
09:00 LSX Welcome Address
Jade Osei-Tutu, Sr. Conference Director, LSX
09:10 Keynote Presentation: Remote Monitoring and the Future of Connected Care
The pandemic underscored the need for connected healthcare, especially for patients who needed to be monitored closely in lower acuity areas of care in the hospital and at home after hospital discharge. There is a continued, growing need and market for remote care, particularly for patients who are transitioning from higher to lower acuity settings and home. The current Medtronic Patient Monitoring business, with a portfolio of hundreds of products and $1.4B in annual revenue, is helping drive development of innovative solutions that improve patient outcomes, reduce healthcare costs, and expand patient access to care–both in and out of the hospital. With the help of advanced technology, remote patient monitoring technologies aim to support patients where they have typically not been well-monitored in low acuity areas of care in the hospital and after they are discharged from the hospital, while also alerting providers to potentially critical changes in their patients' health.
Frank Chan, President, Patient Monitoring, Medtronic
09:30 Panel: Making sense of device data: Helping clinicians take action with their patients
The sophistication of today's patient monitoring technologies has allowed healthcare providers to gain new insights into a patient's condition. While this information has been a game-changer in patient care, the burden of multiple datasets from different sources can cause confusion and can overwhelm providers. How can device makers and digital health companies leverage the power of electronic health records (EHRs) (interconnectivity) and AI to make sense of this information and make it more actionable for clinicians?
Frank Chan, President, Patient Monitoring, Medtronic10:30 Morning Break
11:10 Panel: Value-Based Care and the Future of Health
Corbin Petro, CEO & Co-Founder, Eleanor Health
Jeffrey Scott, President & Chief Medical Officer, Integra Connect
Randy Hawkins, Chief Medical Officer, Transcarent
11:50 Panel: Moving Mental Health into the Mainstream-Scaling Behavioural Healthtech
12:50 Lunch Break
14:00 Panel: Unlocking the Potential of Real-World Evidence and Real-World Data in Healthcare
Danielle Jeddah, Director of Clinical Development, Healthy.io
14:40 Panel: Best Practice when Launching and Running a Digital Therapeutic Clinical Trial
Alankar Gupta, VP, Clinical Development & Medical Affairs, Click Therapeutics
Jessica Lake, Chief Science Officer, Limbix
15:20 Panel: The CVC Playbook-Where are CVCs Placing their Bets?
16:00 Close of Congress
Company Showcases
Showcasing all stages of private & public biotech, healthtech & medtech
2022 showcasing companies included:
.
Day 2–Thursday, September 14th- 11:00
The Healthtech CEO Forum provides a unique, powerful and valuable space for the candid sharing of ideas and experience between executives from 20-30 of the sector's leading digital health and health technology companies.
The forum is designed to foster new ideas and create new relationships between attendees so that they can leave with tangible outcomes and that will drive their businesses and the sector forward.
The forum features 3 x interactive peer review case studies of recent transactions, deals, milestones, or company growth stories which are presented by CEOs or event partners, followed by Q&A and general discussion.
Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of digital health and health technology companies.
Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants.
Benchmark yourself against your peers
Uncover key factors of success
Share war stories and common challenges
Engage in peer-to-peer discussion
Make meaningful connections
Find new ways to help your business thrive
Day 1–Wednesday, September 13th - 16:00
Exclusively for CDOs/CTOs/Global Heads of Digital/Digital Health/Digital Transformation and at top 30 Big Pharma companies, the Pharma Digital Leaders Forum is the regular meeting place for those driving the digitisation at ithe world's largest pharma companies.
The Forum is intimate, exclusive and attendance is by invitation-only.
Co-hosted by:
LSX is the Life Science eXecutive partnering community.
We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses.
contact | privacy policy | good conduct policy | anti-slavery policy | anti-money laundering & financial crime policy | diversity & inclusion policy | terms & conditions
© 2022 all rights reserved by LSX Ltd